D.E. Shaw & Co’s T2 Biosystems, Inc TTOO Stock Holding History

D.E. Shaw & Co’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-46	Closed	-$266K	–	4347
2019 Q4	$266K	Buy	+46	New	+$435K	﹤0.01%	3688
2018 Q4	–	Sell	-24	Closed	-$897K	–	4058
2018 Q3	$897K	Sell	24 -9	-27%	-$296K	﹤0.01%	2759
2018 Q2	$1.27M	Buy	+33	New	+$1.25M	﹤0.01%	2539
2018 Q1	–	Sell	-4	Closed	-$81K	–	3843
2017 Q4	$81K	Buy	+4	New	+$82.6K	﹤0.01%	3508
2017 Q3	–	Sell	-2	Closed	-$32K	–	3655
2017 Q2	$32K	Buy	+2	New	+$40.1K	﹤0.01%	3320
2016 Q3	–	Sell	-2	Closed	-$93K	–	3605
2016 Q2	$93K	Sell	2 -3	-60%	-$135K	﹤0.01%	3258
2016 Q1	$228K	Buy	5 +2	+67%	+$88.4K	﹤0.01%	3143
2015 Q4	$140K	Hold	3	–	–	﹤0.01%	3634
2015 Q3	$144K	Sell	3 -1	-25%	-$66.4K	﹤0.01%	3565
2015 Q2	$335K	Buy	+4	New	+$347K	﹤0.01%	3371

Other funds holding TTOO

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

D.E. Shaw & Co's TTOO Position: Q1 2020 in Review

D.E. Shaw & Co sold out of T2 Biosystems, Inc (TTOO) in Q1 2020, closing a stake of 46 shares — an estimated $266K sold.

D.E. Shaw & Co first reported a position in TTOO in Q2 2015 and held it in 10 quarters. The position peaked at $1.27M in Q2 2018. 39 funds tracked by Wall St. Rank hold TTOO as of Q1 2020.

D.E. Shaw & Co reported no remaining T2 Biosystems, Inc position as of Q1 2020 after selling out during the quarter.
D.E. Shaw & Co sold 46 T2 Biosystems, Inc shares in Q1 2020, an estimated $266K.
D.E. Shaw & Co first reported a position in T2 Biosystems, Inc in Q2 2015 and held it in 10 quarters.
D.E. Shaw & Co's T2 Biosystems, Inc position peaked at $1.27M in Q2 2018.
39 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.